Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
ResMed Inc. has announced a change in beneficial ownership as reported in a recent SEC Form 4 filing. Michael J. Farrell, the Chief Executive Officer, acquired performance-based restricted stock units, which were granted in November 2024 and earned in August 2025 upon meeting performance metrics. This transaction highlights the company’s ongoing commitment to aligning executive compensation with performance, potentially impacting stakeholder confidence and company operations.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$51.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, specializing in the development and manufacturing of equipment related to sleep disorders and respiratory care. The company focuses on providing innovative solutions for patients with sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions, aiming to improve patient outcomes and quality of life.
Average Trading Volume: 890,958
Technical Sentiment Signal: Buy
Current Market Cap: A$64.61B
Learn more about RMD stock on TipRanks’ Stock Analysis page.